These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 27386593)

  • 1. [Farmacological effects of anti-S 100 in release-active form and mechanisms of their realization].
    Khakimova GR; Voronina TA; Dugina YL; Ertuzun IA; Epshtein OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):100-113. PubMed ID: 27386593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic and Antidepressant Effects of Divaza and Brizantin.
    Yakovleva NN; Voronina TA; Suslov NI; Ertuzun IA; Molodavkin GM; Poseva VI; Andreeva VV; Dugina YL; Putilovskii MA; Epshtein OI
    Bull Exp Biol Med; 2015 Oct; 159(6):753-6. PubMed ID: 26519263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults.
    Barchukov VV; Zhavbert ES; Dugina YL; Epstein OI
    Bull Exp Biol Med; 2015 Nov; 160(1):61-3. PubMed ID: 26608378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perspectives of the novel drug divaza in the treatment of chronic cerebral ischemia].
    Tanaeva KK; Dugina IuL; Kachaeva EV; Epshteĭn OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):100-4. PubMed ID: 25473662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiamnesic effects divaza and its component model β-amyloid amnesia].
    Ganinа KK; Duginа YL; Zhavbert ES; Ertuzun IA; Epstein OI; Mukhin VN; Abdurasulova IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):69-74. PubMed ID: 27735902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spectrum of psychotropic effects and mechanism of action of ultra low doses of the antibodies to S-100 protein (proproten)].
    Voronina TA; Epshteĭn OI; Molodavkin GM; Sergeeva SA; Kraĭneva VA
    Radiats Biol Radioecol; 2003; 43(3):291-3. PubMed ID: 12881981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ultralow doses of antibodies to S-100 antigen (Proproten-100) on spatial learning in rats.
    Pavlov IF
    Bull Exp Biol Med; 2005 Feb; 139(2):196-7. PubMed ID: 16027805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome].
    Tsukanov VV; Rzhavicheva OS; Vasjutin AV; Dunaevskaja OV; Tonkih JL; Bronnikova EP
    Ter Arkh; 2016; 88(8):40-45. PubMed ID: 27636926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
    Ganina KK; Dugina YL; Zhavbert ES; Ertuzun IA; Epstein OI; Abdurasulova IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):78-82. PubMed ID: 26356401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic activity of the antialcohol preparation Proproten-100.
    Krylov EN
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():176-80. PubMed ID: 12949691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant properties of antibodies to serotonin, brain-specific S100 protein, and delta sleep-inducing peptide.
    Meshcheryakov AF
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():23-5. PubMed ID: 12949638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective activity of proproten in rats with experimental local photothrombosis of the prefrontal cortex.
    Romanova GA; Voronina TA; Dugina YL; Martyushev-Poklad AV; Sergeeva SA; Epstein OI; Barskov IV
    Bull Exp Biol Med; 2005 Apr; 139(4):404-7. PubMed ID: 16027865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proproten-100 in the therapy of patients with the alcohol withdrawal syndrome.
    Gofman AG; Pyatnitskaya IN; Valentik YV; Krylov EN; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():167-70. PubMed ID: 12949689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tenoten on anxiety and depression disorders in patients with epilepsy.
    Delger AB; Avakyan GN; Oleinikova OM; Bogomazova MA; Chromych EA; Lagutin IuV
    Bull Exp Biol Med; 2012 Sep; 153(5):704-6. PubMed ID: 23113263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficiency of Proproten-100 during the therapy of patients with alcoholism in the stage of therapeutic remission.
    Bokhan NA; Abolonin AF; Krylov EN; Vetlugina TP; Ivanova SA; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():171-5. PubMed ID: 12949690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical study of proproten-100 for mutagenicity.
    Voronova OL
    Bull Exp Biol Med; 2009 Sep; 148(3):547-8. PubMed ID: 20396737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat.
    Castagne V; Lemaire M; Kheyfets I; Dugina JL; Sergeeva SA; Epstein OI
    J Pharm Pharmacol; 2008 Mar; 60(3):309-16. PubMed ID: 18284810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Erythropoietin-Stimulating Action of Anti-Erythropoietin Release-Active Antibodies in Complex Treatment of Experimental Anemia during Gestation.
    Burmina YV; Udut EV; Zhdanov VV; Sotnikova LS; Miroshnichenko LA; Simanina EV; Polyakova TY; Zyuz'kov GN; Chaikovskii AV; Stavrova LA; Epshtein OI; Dygai AM
    Bull Exp Biol Med; 2016 Apr; 160(6):737-41. PubMed ID: 27165080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of Very Low Doses of Antibodies to S100 Protein in the Complex Therapy of Functional Dyspepsia in Children.
    Polivanova TV; Smirnova OV; Gorbacheva NN; Vshivkov VA
    Bull Exp Biol Med; 2015 Jul; 159(3):341-3. PubMed ID: 26212808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenoten in the therapy of patients with moderate cognitive impairment.
    Duma SA; Shishkin SV
    Bull Exp Biol Med; 2009 Aug; 148(2):353-6. PubMed ID: 20027370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.